1. Home
  2. SOHO vs LYRA Comparison

SOHO vs LYRA Comparison

Compare SOHO & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOHO
  • LYRA
  • Stock Information
  • Founded
  • SOHO 2004
  • LYRA 2005
  • Country
  • SOHO United States
  • LYRA United States
  • Employees
  • SOHO N/A
  • LYRA N/A
  • Industry
  • SOHO Real Estate Investment Trusts
  • LYRA Medical/Dental Instruments
  • Sector
  • SOHO Real Estate
  • LYRA Health Care
  • Exchange
  • SOHO Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • SOHO 18.0M
  • LYRA 15.0M
  • IPO Year
  • SOHO 2004
  • LYRA 2020
  • Fundamental
  • Price
  • SOHO $0.79
  • LYRA $6.67
  • Analyst Decision
  • SOHO Hold
  • LYRA Buy
  • Analyst Count
  • SOHO 1
  • LYRA 2
  • Target Price
  • SOHO $1.50
  • LYRA $16.00
  • AVG Volume (30 Days)
  • SOHO 18.2K
  • LYRA 29.9K
  • Earning Date
  • SOHO 08-12-2025
  • LYRA 08-18-2025
  • Dividend Yield
  • SOHO N/A
  • LYRA N/A
  • EPS Growth
  • SOHO N/A
  • LYRA N/A
  • EPS
  • SOHO N/A
  • LYRA N/A
  • Revenue
  • SOHO $182,158,199.00
  • LYRA $1,185,000.00
  • Revenue This Year
  • SOHO $13.93
  • LYRA N/A
  • Revenue Next Year
  • SOHO N/A
  • LYRA $139.18
  • P/E Ratio
  • SOHO N/A
  • LYRA N/A
  • Revenue Growth
  • SOHO 3.11
  • LYRA N/A
  • 52 Week Low
  • SOHO $0.59
  • LYRA $3.81
  • 52 Week High
  • SOHO $1.54
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • SOHO 35.68
  • LYRA 36.02
  • Support Level
  • SOHO $0.80
  • LYRA $6.54
  • Resistance Level
  • SOHO $0.84
  • LYRA $7.10
  • Average True Range (ATR)
  • SOHO 0.03
  • LYRA 0.54
  • MACD
  • SOHO -0.01
  • LYRA 0.03
  • Stochastic Oscillator
  • SOHO 4.43
  • LYRA 14.89

About SOHO Sotherly Hotels Inc.

Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: